Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 870 of 6351
-
Gene therapy zolgensma tested in kids with SMA who stopped other drugs
Disease control CompletedThis was a Phase IIIb open-label, single arm, multi-center study to evaluate the safety, tolerability and efficacy of OAV101B in participants with SMA aged 2 to \<18 years after the discontinuation of treatment with nusinersen or risdiplam. The study aimed to enroll approximately…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can discarded bone reveal the secrets to stronger bones?
Knowledge-focused Recruiting nowDiseases of bone associated with ageing, including osteoporosis (OP) and osteoarthritis (OA), reduce bone mass, bone strength and joint integrity. Current non-surgical approaches are limited to pharmaceutical agents that are not disease modifying and have poor patient tolerabilit…
Sponsor: Relation Therapeutics • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New Clot-Busting catheter shows promise for lung blood clots
Disease control CompletedEvaluation of initial safety and clinical feasibility of the Hēlo PE Thrombectomy System for thrombectomy in acute submassive pulmonary embolism (PE).
Sponsor: Endovascular Engineering • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug shows promise for Long-Term control of IBD
Disease control OngoingThe primary objective of the study is to evaluate the efficacy of 2 different maintenance dose regimens of TEV-48574 subcutaneous (sc) administered every 4 weeks (Q4W) in adult participants with inflammatory bowel disease (IBD). Secondary objectives of the study are to: * evalu…
Phase 2 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Promising new combo aims to improve lung cancer treatment
Disease control OngoingThis study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab in combination with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squam…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a dual protein blocker shrink Hard-to-Treat tumors?
Disease control OngoingThis is a Phase1 study to assess the safety, PK, PD and efficacy of HM97662, EZH1/2 dual inhibitor, in solid tumors. The study is comprised of Dose-Escalation Part followed by randomized Dose-Ranging Part and Dose-Expansion Part. Dose-Escalation Part is planned with a 3+3 Dose-Es…
Phase 1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Eczema drug dupilumab shows promise in skin of color patients
Disease control CompletedThe study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema, is a condition that causes the skin to become itchy, dry, and cracked. From the previous studies on the study drug, it is seen that th…
Phase 4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
App aims to help pregnant women kick the habit
Disease control Recruiting nowThe objectives of this project are to develop, implement, and test the feasibility and effectiveness of an artificial intelligence adaptive mobile pregnancy tobacco cessation app-based intervention using deep tailoring and a self-nominated support person, and to build mHealth res…
Sponsor: Michigan State University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Precision dosing could make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowAlemtuzumab is an antibody that reduces the strength of the immune system that is given in preparation for allogeneic hematopoietic cell transplant (HCT). In this research study the investigators want to find out if they can adjust the dose of alemtuzumab used as part of allogene…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Which lymphoma drug combo works best? a new study aims to find out
Disease control CompletedDescribe the application status of different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), observe the therapeutic efficacy and safety of the treatment modalities.
Sponsor: Fudan University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Blood test may replace scans for heart attack staging
Diagnosis CompletedTROP-MI-STAGE is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction as defined by the stages of myocardial injury in CCS-AMI …
Sponsor: Rohan Dharmakumar • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Heart failure patients get a tiny shunt without a permanent implant
Disease control Recruiting nowProspective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.
Sponsor: Alleviant Medical, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New combo aims to boost immune cells after lung cancer therapy
Disease control Recruiting nowTo learn about the effects of the investigational drug NKTR-255 in combination with the standard drug durvalumab on locally advanced NSCLC when given after CRT.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New combo therapy shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis is a multi-center, open-label, randomized, phase 2/3 trial of the bispecific antibody CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced or metastatic biliary tract cancers.
Phase 2/3 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Your genes may determine if the Morning-After pill works
Disease control Recruiting nowThe purpose of this study is to learn more about why some people are at greater risk for oral emergency contraceptive failure while others are not. The investigators want to learn if genetic differences impact the risk of emergency contraception failure.
Phase 4 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a Skin-Repairing cream soothe eczema?
Symptom relief CompletedThe application of DermControl®, a repair cream based on hyaluronic acid, sh-oligopeptide-1 and polyphenols, in combination with topical corticosteroids, could help to improve epidermal barrier function in patients with atopic dermatitis, improving their symptoms and Quality of L…
Sponsor: Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L. • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New combo therapy hopes to tackle tough bile duct cancer
Disease control Recruiting nowExplore the impact of the first-line application of Pembrolizumab with or without Lenvatinib or chemotherapy, on the survival, disease progression, and drug safety of patients with advanced biliary tract cancers
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug aims to stop Flare-Ups in rare autoimmune disease
Disease control OngoingThis study aims to examine the efficacy and safety of obexelimab for the prevention of flare of IgG4-related disease (IgG4-RD)
Phase 3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a simple drink sharpen aging brains? a new trial puts it to the test
Disease control CompletedTo evaluate the effect of 16-weeks consumption of Mitocholine on Executive Function and Homocysteine levels in a population experiencing Mild Cognitive Impairment. The study will also include measures of memory, language, S-adenosylmethionone (SAM), Betaine, Choline.
Sponsor: Mitocholine Ltd • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could your own fat heal Crohn's fistulas and prevent a colostomy bag?
Disease control Ongoingmulticentre randomized controlled prospective study aimed at evaluating the efficacy of the infiltration of microfractured adipose tissue in the healing of perianal fistulas not-responding to treatment with biologics, in order to improve the quality of life and significantly redu…
Sponsor: Lipogems International spa • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC